Hospital Universitari Vall d'Hebron

Spain

es.png

Contact Information for physicians/patients

Particular rare liver disease expertise of the centre

Hepatology Department and Paediatric Hepatology and Liver Transplant Unit currently participates in multiple research projects, both national and international. We are especially active in liver transplantation for rare diseases and advanced therapies (enzymatic replacement therapy, gene editing, gene therapy, and cell transplantation) for metabolic diseases (paediatric and adult).
Our expertise is focused in the multidisciplinary care of patients with Urea Cycle Disorders, Organic acidemias, Lysosomal Diseases, Tyrosinemia, Wilson Disease, Autoimmune Hepatitis and Primary Biliary Cholangitis, vascular liver diseases, alpha-1 antitrypsin deficiency among others.
We have also a special interest in paediatric cholestatic liver diseases (Biliary Atresia, Choledocal Cyst, Progressive Familiar Intrahepatic Cholestasis, Biliary Acid Synthesis Defects etc).

Further diseases covered:
  • Primary Sclerosing Cholangitis (PSC)
  • IgG4-related Liver Disease
  • Cystic Liver Disease
  • Intrahepatic Cholangiocarcinoma (iCCA)

ERN Representatives

  • portrait-placeholder.png

    Jesús Quintero Bernabeu

    Lead Clinician, Pediatric Hepatology and Liver Transplant Unit

  • victor_vargas_picture.jpg

    Victor Vargas Blasco

    Lead Clinician, Hepatology Department


ERN Team and Contact


Centre information

The Vall d’Hebron University Hospital (VHUV) includes a number of centres within the Catalan Institute of Health network, with extensive experience in hepatology (adult and paediatric) and solid organ transplantation as well as rare diseases (RD). The VHUH is the hospital that participates in more ERN in Spain. Moreover VHUH has 26 CSUR accreditations as center of reference of tertiary diseases in Spain (the center with more accreditation all around the country). Since 2019, VHUH is the headquarters of the International Conference of Rare Diseases and Orphan Drugs (ICORD), a world leader in minority diseases.
The VHUH has a specific unit of Rare Diseases and has the tools to diagnose and treat these patients There are more than 100 specialized professionals dedicated to the care of more than 2,000 RD. It is the hospital that attends more RD from our country, being one of the leading hospitals in Europe in this field. VHUHs have a clear desire to place the patient in the centre of the healthcare process. Hepatic Rare Diseases are one of the most successful examples of this model, involving professionals from different specialties in the care of patients, always seeking the benefit of the patient. This interaction is mainly done in multidisciplinary Committees such as Paediatric Liver Transplant Committee, Adult Liver Transplant Committee, Hepatology Committee (paediatric and adult), Complex Hepatic Surgery Committee, Adult Hepatobiliary Tumours Committee, Paediatric hepatobiliary tumours Committee.
We have an important participation in the decision forums both at the political level (Spanish Ministry of Health, Autonomic Health Council and Advisory Commission on Minority Illnesses) as well as national scientific societies (AEP, SEGHNP, AEEH, SEPD, SET, SETH) and international (IPTA, ESPGHAN,ILTS, EASL). We actively participate in work groups (Graft Injury Group, ESPGHAN Hepatology Committee, Hepatology Group of the SEGHNP, Baveno group etc) and in Advisory Commissions (Advisory Commission for Lysosomal Diseases, Hepatic Transplant Advisory Commission, Live Donor Advisory Commission for Hepatic Transplantation).